Xeris Pharmaceuticals Inc (XERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,519 | 45,716 | 42,045 | 32,269 | N/A |
| Marketable Securities | 56,030 | 66,917 | 0 | N/A | N/A |
| Receivables | 4,693 | 2,869 | 1,199 | 101 | N/A |
| Inventories | 2,176 | N/A | N/A | N/A | N/A |
| TOTAL | $87,483 | $117,899 | $44,053 | $33,174 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 7,853 | 2,034 | 788 | 312 | N/A |
| Investments And Advances | 13,231 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 420 | 95 | 157 | 47 | 0 |
| TOTAL | $21,504 | $2,129 | $945 | $359 | $N/A |
| Total Assets | $108,987 | $120,028 | $44,998 | $33,533 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,603 | 866 | 1,976 | 1,315 | 0 |
| Accrued Expenses | 3,332 | N/A | 2,557 | 902 | N/A |
| Other current liabilities | 284 | 1,092 | 93 | 47 | N/A |
| TOTAL | $27,338 | $10,172 | $4,860 | $2,527 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 58,305 | 31,890 | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | 234 | 263 | N/A |
| Other Non-Current Liabilities | 1,832 | 2,560 | 90 | 0 | 0 |
| TOTAL | $67,213 | $34,450 | $90 | $42 | $N/A |
| Total Liabilities | $94,551 | $44,622 | $4,950 | $2,569 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,570 | 26,810 | N/A | N/A | N/A |
| Common Shares | 3 | 2 | 1 | 1 | N/A |
| Retained earnings | -246,245 | -120,665 | -60,585 | -34,031 | N/A |
| Other shareholders' equity | 43 | -52 | 97,878 | 62,898 | 0 |
| TOTAL | $14,436 | $75,406 | $40,048 | $30,964 | $N/A |
| Total Liabilities And Equity | $108,987 | $120,028 | $44,998 | $33,533 | $0 |